A profitable company with growing sales, with elevated risk.
Going well
Sales up 40% in the latest quarter vs a year ago
Profitable
Watch out for
Share count growing 14.7% a year (dilution)
2 offering filings in 6 months (may sell new shares)
Money moves
No insider buying or selling in the last 30 days
Institutions cut 2.6% from their holdings in the quarter ending June 2026 (71 bought, 61 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$1.010.0% that day
Company value
$156M
Share price times all shares
Price vs sales
3.1x
No profit over the last year, so this compares value with sales instead
Cash vs value
53%
A big cushion: cash is a large part of what the company is worth
From CHRS's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26
$14.3M+40% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $50.9M, up 61% from the 12 months before.
What the price assumes
Your guesses, our math
Move the sliders to your own view of CHRS. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$189M
Profit in 5 years$19M
Price these guesses point to$1.14+13% vs $1.01 todayAbout +2.5% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales would have to grow about 27% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
The checklist Warren Buffett-style investors use. Annual numbers for 2025.
0/3Weak
MissProfitable every yearSteady profits, not one good year.4 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$138.5M
MissShare count not growingNot diluting owners. Falling means buybacks.+50.9% in 3 years
Revenue
$42.2M
Current ratio
1.47x
short-term assets / bills due
Free cash flow
-$138.5M
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, debt under half of equity, net margin 10%+, gross margin 40%+. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026
Reported Aug 5
Revenue
$14.3M
+39.5% YoY
EPS
-$0.13
vs $2.57
Op. margin
-226.0%
+217.6 pts
Gross margin
70.4%
+3.5 pts
Free cash flow
-$62.1M
Share count
+33.4%
vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trend
No trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
This week
0
Normal week
0.7
vs normal
0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady-2.6%
Institutions cut 2.6% from their holdings. 71 bought, 61 sold.
Shares held by institutions70.4M
Sep '24Jun '26
Safety check
From SEC filings
Share count growthYearly rate, last 3 years
+17.8%
Cash runwayAt last year's cash burn
7 months
Debt to equityLatest balance sheet: debt compared with what owners have
Total liabilities $130.3M
Shares outstandingLatest reported
155M
Why elevated risk
Share count growing 17.8% a year (dilution)
2 offering filings in 6 months (may sell new shares)
Auditor change
Earnings reports
Last 12
Next reportAround Nov 5 (est.)Estimated from the same quarter last year
Results filedAug 5
Results filedMay 11
Results filedMar 9
Results filedJan 13
Results filedNov 6, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days